The Scientist Speaks thescientistspeaks

The field of psychedelics research has exploded in recent years, as scientists dig deeper into the neuroscience and pharmacology of hallucinogens and how their unique properties can be harnessed to understand and treat depression, anxiety, post-traumatic stress disorder, Alzheimer’s disease, dementia, and neurodegenerative diseases. Remarkably, the human body produces its own endogenous psychedelics, the reasons for which have implications for understanding the ordinary and extraordinary states of human consciousness, from creativity and dreaming to near death experiences.
In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Steven Barker, a professor emeritus at Louisiana State University to learn more about the human body’s ability to produce hallucinogenic compounds and their roles in physiological processes.
More on this topic
https://www.the-scientist.com/features/natural-high-endogenous-psychedelics-in-the-gut-and-brain-71301
https://www.the-scientist.com/infographics/infographic-what-a-trip-71303
The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research.

Jonathan Weissman and Luke Gilbert share how they developed several CRISPR-based epigenetic editors and how these tools differ from traditional CRISPR.

Scientists discuss the advent of robotically run research and the new era of academic cloud labs on the horizon.

Researchers apply the principles of synthetic biology to address some of the most pressing human health challenges. In what some consider a science and an artform, scientists use bacterial components in creative ways to create synthetic cells for cancer research.
In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Kate Adamala, an assistant professor at the University of Minnesota and a synthetic biologist working on engineering synthetic cells, to learn more about the latest advances in using synthetic biology for cancer therapy applications.
The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Namocell – a Bio-Techne brand.

Neurobiologists, computer scientists, and engineers join forces to grow mini brains using automation and make their technologies smarter with artificial intelligence.

Fecal transplantation is an established procedure for controlling recurrent Clostridium difficile infection by replenishing healthy bacteria in the gut. Researchers explore novel applications of fecal transplantation for treating other conditions, including psychiatric disorders. In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Ian Carroll, an assistant professor in the Department of Nutrition at the University of North Carolina at Chapel Hill, and Kylie Reed, a PhD candidate in Carroll’s laboratory, to learn how the current understanding of treating infectious disease with fecal transplantation drives new applications of this therapy for psychiatric conditions such as eating disorders.
 
The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research.